HealthcareBrainstorm KOL event today on NurOwn in Alzheimer'sJul. 08, 2020 6:42 AM ETBrainstorm Cell Therapeutics Inc. (BCLI) StockBCLIBy: Douglas W. House, SA News Editor2 Comments Brainstorm Cell Therapeutics (NASDAQ:BCLI) will host a Key Opinion Leader (KOL) webinar today at 8:15 am ET on its program in Alzheimer's disease (AD). It recently announced its plan to develop NurOwn in AD. A Phase 2 clinical trial is next up. Recommended For YouAbout BCLI StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgBCLI--Brainstorm Cell Therapeutics Inc.Trending AnalysisTrending News